Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
ASH Updates on Lymphomas: 1L (Axi-Cel) in High-Risk DLBCL, Safety, Dosing and Feasibility of MB-CART2019 in R/R B-NHL, BTKi/mTOR/IMID Combo for R/R Richter's Transformation and De-Novo DLBCL, CNS Lymphoma Prevention, Primary CNS Lymphoma
Comments 0
Login to view comments.
Click here to Login
